FCVAX | VSIAX | FCVAX / VSIAX | |
Total Expense Ratio | 1.26 | 0.07 | 1,800% |
Annual Report Gross Expense Ratio | 1.26 | 0.07 | 1,800% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | -3.615 | -2.752 | 131% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.29B | 54B | 8% |
Annual Yield % from dividends | 0.34 | 2.23 | 15% |
Returns for 1 year | 0.12 | 5.51 | 2% |
Returns for 3 years | 6.80 | 28.21 | 24% |
Returns for 5 years | 65.27 | 83.56 | 78% |
Returns for 10 years | 1.52 | 83.37 | 2% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VXZ | 61.02 | 1.81 | +3.05% |
iPath® B S&P 500® VIX Md-Trm Futs™ ETN | |||
UMI | 50.86 | 0.16 | +0.31% |
USCF Midstream Energy Income ETF | |||
GLOV | 53.87 | -0.50 | -0.92% |
Goldman Sachs ActBt Wld Lw Vl Ps Eq ETF | |||
SPLG | 70.22 | -0.79 | -1.11% |
SPDR® Portfolio S&P 500® ETF | |||
CURE | 80.75 | -1.31 | -1.60% |
Direxion Daily Healthcare Bull 3X ETF |